Abstract 1229: Prognostic significance of telomere length in B-chronic lymphocytic leukemia patients in early stage disease
Authors: Mirjam Hoxha, Sonia Fabris, Luca Agnelli, Laura Dioni, Valentina Bollati, Ciceri Gabriella, Fortunato Morabito, Giovanna Cutrona, Serena Matis, Massimo Gentile, Giorgio L. Deliliers, Pier A. Bertazzi, Manlio Ferrarini, Andrea Baccarelli, Antonino Neri
Journal: Cancer Research (2011)

Abstract BACKGROUND: Cell chronic lymphocytic leukemia (CLL) is a genetically heterogeneous disease with a variable outcome. The identification of factors that could predict the clinical course of early-stage CLL represents a crucial objective in this malignancy. Although previous studies indicated that telomere length may be a useful independent prognostic factor in the risk stratification of CLL patients, limited information has been reported in asymptomatic early stage patients (Binet stage A). OBJECTIVES: The present study was aimed at investigating the association of telomere length with the major biological and cytogenetic markers known to predict clinical outcome in CLL. The global DNA methylation of repeat sequences, Alu and LINE-1, both associated with chromosomal instability, was also studied. Finally, correlation with disease progression, measured as the time elapsed from diagnosis to first treatment, was evaluated. METHODS: We measured relative telomere length (RTL) by real-time PCR in a panel of highly purified (&amp;gt;90%) peripheral mononuclear CD19+ cells from 7 healthy donors and 77 untreated CLL patients. All cases were characterized by FISH for the most frequent chromosomal aberrations, namely trisomy of chromosome 12 and deletions at 17p13.1, 11q22.3 and 13q14.3 loci (Fabris et al. GCC, 2008). Molecular markers including mutation status of the heavy chain variable regions of immunoglobulin genes (IGVH), the expression of the 70-kd zeta-chain T-cell receptor-associated protein kinase (ZAP-70) and CD38 cell surface antigen protocols were previously reported (Cutrona et al. Haematologica, 2008). A quantitative bisulfite-PCR Pyrosequencing method was used to evaluate methylation of Alu and LINE-1. RESULTS: We found a significantly lower RTL values in CLLs (median RTL=0.4 IQR 0.3-0.6) as compared with controls (median RTL=1.0 IQR 0.9-1.3) (P &amp;lt; 0.001). A progressive and significant RTL decrease in low (13q- and normal karyotype), intermediate (+12) and high (11q- and 17p-) cytogenetic risk categories (P for trend =0.008) was observed. Patients with IGVH mutated genes had longer telomeres than patients with unmutated genes (P&amp;lt;0.001). No significant association between telomere length and either CD38 or ZAP70 expression was found. In line, telomere shortening was significantly correlated with hypomethylation of Alu (P=0.048) and LINE-1 (P=0.001), indicating a contribution to chromosome instability. Finally, follow-up analysis, available for 63 patients, showed a significantly higher risk of starting treatment for patients with shorter telomeres (P=0.037) CONCLUSIONS: Our results extended previous evidence that telomere length could be used as marker for the identification of different CLL prognostic subgroups. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 1229. doi:10.1158/1538-7445.AM2011-1229